罗伯特·莫奇
Robert Mauch
领导U.S.大型Wholesalers: Health Care企业运营
专业领域
Healthcare management, life sciences
核心贡献
领导U.S.大型Wholesalers: Health Care企业运营
Leading large-scale Wholesalers: Health Care operations in U.S.
最新观点
-
康德乐(美源伯根)CEO莫奇在2026年11月4日发布的2026财年四季度及全年业绩公告中表示,2026财年是公司关键一年:通过收购OneOncology扩展MSO平台、锐化业务组合并创下纪录业绩,这些举措为公司在清晰战略优先级下保持强劲势头奠定了基础。当季营收884亿美元(同比+5.5%),调整后EPS 4.66美元(同比+21.4%),季度股息上调10%。
"Fiscal 2026 was a pivotal year for Cencora, as we expanded our MSO platform through the acquisition of OneOncology, sharpened the focus of our portfolio and delivered record results. These actions laid the foundation and position us to move forward with significant momentum and clear strategic priorities," said President and CEO Robert Mauch.
-
在Wells Fargo医疗大会上,Mauch表示Cencora正处于优秀的2026财年,增长继续聚焦于专科制药领域。
We're in the midst of an excellent fiscal 2026. We reported last month, our third quarter earnings, which demonstrated continued growth in our areas of focus, which really are the specialty pharmaceutical areas.
-
Q3 FY2026收入增长至848亿美元并上调EPS指引,称业绩反映业务韧性,对全年指引保持信心,同时在降低债务方面取得进展
Cencora delivered solid results in our second quarter as our team members continued to execute to meet the needs of our customers. Our fiscal 2026 guidance reflects the strength of our business and focus on our strategy to create long-term value.